Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Pam Gore Receives Beverley Boesch Legacy Award
Auto Casualty
Virtual Event
Pot Policies in Workers' Compensation and Auto Casualty [Webinar]
On-Demand
Even as the pandemic takes center stage, marijuana legislation has been makin
Workers' Comp
Blog
Staying Connected During COVID-19
We asked our Field Case Managers how they were staying connected to their injured workers and finding meaning and purpose during the COVID-19 pande
Workers' Comp
Article
Potential Drug Therapy Treatments for COVID-19: Impact on Workers’ Compensation
As response to the COVID-19 pandemic shifts into new phases—parts of the United States are reopening and businesses and many states are considering
Mitchell
News Release
COVID-19 Drug Therapy Treatments: Potential Impact on Workers' Comp
Mitchell
News Release